X

Journal of Clinical Pharmacy and Therapeutics

Journal of Clinical Pharmacy and Therapeutics
Gastrointestinal events with PARP inhibitors in cancer patients: A meta-analysis of phase II/III randomized controlled trials.

This authors conducted this meta-analysis of RCTs to fully investigate the incidence and the relative risk of GI events in cancer patients receiving PARP inhibitors.

Journal of Clinical Pharmacy and Therapeutics
11/02/2020
Uterine sarcoma with posterior reversible encephalopathy syndrome associated with pazopanib.

The case objective is to report on a case of posterior reversible encephalopathy syndrome associated with pazopanib.

Journal of Clinical Pharmacy and Therapeutics
10/12/2020
Subscribe to Journal of Clinical Pharmacy and Therapeutics

source list reference

#7d60d9
#2694a4
#85eb24
#352625
#4d4537
#d2093c
#8e3f1c
#76b6c3
#bfcfc8
#c61417
#67e25b
#efef71
#42fc9a
#cc529a
#c59445
#c8cc0c
#e8085a
#97d1a0
#b61f77
#a153ac
#e7f6e3
#9a8c2c
#a9c507
#990677
#4a7bab
#89f67c
#49a21d
#2c990a
#d7da81
#575662
#49cde9
#c20fce
#d95d39